Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
2014-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384ffd511c4439dad0aa1f61f9c2118e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2dc3b89f8413a7fe0a565d3db48327e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9353b821c233248c52d275038736a90 |
publicationDate |
2015-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015044880-A1 |
titleOfInvention |
Oral liquid pharmaceutical composition of a dpp-iv inhibitor |
abstract |
The present invention relates to oral liquid pharmaceutical compositions comprising a DPP-IV inhibitor and processes for preparing the oral liquid pharmaceutical compositions. The invention also relates to oral liquid pharmaceutical compositions comprising a DPP-IV inhibitor and processes for preparing the oral liquid pharmaceutical compositions devoid of sugar based sweeteners. It further relates to a method of treating diabetes by administering said oral liquid pharmaceutical compositions. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3811930-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022387427-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170033684-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7279134-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018123099-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102442536-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017047970-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021078964-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3359156-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022025121-A |
priorityDate |
2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |